Related Experiment Video
Updated: Apr 23, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Should statins be used to prevent cardiovascular disease in patients on hemodialysis?
Insights
Initiating statin therapy for hemodialysis patients offers limited cardiovascular benefits compared to non-dialysis individuals. Guidelines recommend against starting statins in hemodialysis-dependent chronic kidney disease (CKD) patients but suggest continuing them if already prescribed, with careful myopathy monitoring.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Cardiovascular disease is a leading cause of mortality in patients with chronic kidney disease (CKD).
- Statins are widely used to manage cardiovascular risk in the general population.
- Evidence regarding the efficacy of statin initiation in hemodialysis patients is evolving.
Purpose of the Study:
- To evaluate the cardiovascular benefits of initiating statin therapy in patients undergoing hemodialysis.
- To assess the current recommendations and evidence for statin use in hemodialysis-dependent CKD patients.
Main Methods:
- Review of current scientific evidence and clinical guidelines.
- Analysis of comparative cardiovascular outcomes between hemodialysis and non-hemodialysis patients on statin therapy.
Main Results:
- Initiation of statin therapy in hemodialysis patients does not yield the same cardiovascular benefits as in non-hemodialysis patients.
- Kidney Disease: Improving Global Outcomes (KDIGO) guidelines advise against initiating statins in hemodialysis-dependent CKD patients.
- Continuation of existing statin therapy is recommended for patients at the time of hemodialysis initiation.
Conclusions:
- Statin therapy initiation is not recommended for hemodialysis-dependent CKD patients due to limited cardiovascular benefits.
- Continued statin therapy for patients already on treatment before starting hemodialysis is suggested.
- Increased vigilance for statin-induced myopathy is crucial in hemodialysis patients receiving statin therapy.
Abstract:
There now exists current evidence that the initiation of statin therapy in patients on hemodialysis does not provide the same cardiovascular benefit as in non-hemodialysis patients. The KDIGO guidelines suggest not to initiate statin therapy in hemodialysis-dependent CKD patients, but to continue therapy in patients who are already on a statin at the time of hemodialysis initiation. A closer monitoring of myopathy is warranted for hemodialysis patients on a statin therapy.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Hemodialysis I: Introduction
Hemodialysis III: Nursing Management
Coronary Artery Disease IV: Preventive Measures
Hemodialysis II: Procedure and Complications
